Source link : https://newshealth.biz/health-news/do-parp-inhibitors-benefit-patients-with-ovarian-cancer/
First-line PARP inhibitor maintenance after platinum chemotherapy reduces progression risk in certain patients with ovarian cancer but increases the risk for serious toxicity. Medscape Medical News Source link : https://www.medscape.com/viewarticle/do-parp-inhibitors-benefit-patients-ovarian-cancer-2025a1000xa6?src=rss Author : Publish date : 2025-11-28 05:16:00 Copyright for syndicated content belongs to the linked Source.
The post Do PARP Inhibitors Benefit Patients With Ovarian Cancer? first appeared on News Health.
—-
Author : News Health
Publish date : 2025-11-28 05:16:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8